Authors:
DOLMAN CS
MUELLER BM
LODE HN
XIANG R
GILLIES SD
REISFELD RA
Citation: Cs. Dolman et al., SUPPRESSION OF HUMAN PROSTATE CARCINOMA METASTASES IN SEVERE COMBINEDIMMUNODEFICIENT MICE BY INTERLEUKIN-2 IMMUNOCYTOKINE THERAPY, Clinical cancer research, 4(10), 1998, pp. 2551-2557
Authors:
DREIER T
LODE HN
XIANG R
DOLMAN CS
REISFELD RA
KANG AS
Citation: T. Dreier et al., RECOMBINANT IMMUNOCYTOKINES TARGETING THE MOUSE TRANSFERRIN RECEPTOR - CONSTRUCTION AND BIOLOGICAL-ACTIVITIES, Bioconjugate chemistry, 9(4), 1998, pp. 482-489
Authors:
SEITZ G
GEBHARDT S
BECK JF
BOHM W
LODE HN
NIETHAMMER D
BRUCHELT G
Citation: G. Seitz et al., ASCORBIC-ACID STIMULATES DOPA SYNTHESIS AND TYROSINE-HYDROXYLASE GENE-EXPRESSION IN THE HUMAN NEUROBLASTOMA CELL-LINE SK-N-SH, Neuroscience letters, 244(1), 1998, pp. 33-36
Authors:
LODE HN
XIANG R
BECKER JC
GILLIES SD
REISFELD RA
Citation: Hn. Lode et al., IMMUNOCYTOKINES - A PROMISING APPROACH TO CANCER-IMMUNOTHERAPY, Pharmacology & therapeutics (Oxford), 80(3), 1998, pp. 277-292
Authors:
LODE HN
DREIER T
XIANG R
VARKI NM
KANG AS
REISFELD RA
Citation: Hn. Lode et al., GENE-THERAPY WITH A SINGLE-CHAIN INTERLEUKIN-12 FUSION PROTEIN INDUCES T-CELL-DEPENDENT PROTECTIVE IMMUNITY IN A SYNGENEIC MODEL OF MURINE NEUROBLASTOMA, Proceedings of the National Academy of Sciences of the United Statesof America, 95(5), 1998, pp. 2475-2480
Authors:
XIANG R
LODE HN
DREIER T
GILLIES SD
REISFELD RA
Citation: R. Xiang et al., INDUCTION OF PERSISTENT TUMOR-PROTECTIVE IMMUNITY IN MICE CURED OF ESTABLISHED COLON-CARCINOMA METASTASES, Cancer research, 58(17), 1998, pp. 3918-3925
Authors:
LODE HN
REISFELD RA
HANDGRETINGER R
NICOLAOU KC
GAEDICKE G
WRASIDLO W
Citation: Hn. Lode et al., TARGETED THERAPY WITH A NOVEL ENEDIYENE ANTIBIOTIC CALICHEAMICIN THETA(I)(1) EFFECTIVELY SUPPRESSES GROWTH AND DISSEMINATION OF LIVER METASTASES IN A SYNGENEIC MODEL OF MURINE NEUROBLASTOMA, Cancer research, 58(14), 1998, pp. 2925-2928
Authors:
LODE HN
XIANG R
DREIER T
VARKI NM
GILLIES SD
REISFELD RA
Citation: Hn. Lode et al., NATURAL-KILLER CELL-MEDIATED ERADICATION OF NEUROBLASTOMA METASTASES TO BONE-MARROW BY TARGETED INTERLEUKIN-2 THERAPY, Blood, 91(5), 1998, pp. 1706-1715
Authors:
LODE HN
XIANG R
VARKI NM
DOLMAN CS
GILLIES SD
REISFELD RA
Citation: Hn. Lode et al., TARGETED INTERLEUKIN-2 THERAPY FOR SPONTANEOUS NEUROBLASTOMA METASTASES TO BONE-MARROW, Journal of the National Cancer Institute, 89(21), 1997, pp. 1586-1594
Authors:
LODE HN
XIANG R
DREIER T
GILLIES SD
REISFELD RA
Citation: Hn. Lode et al., TARGETED CYTOKINE DELIVERY WITH RECOMBINANT ANTIBODY FUSION PROTEINS FOR THERAPEUTIC INTERVENTION, European journal of cancer, 33, 1997, pp. 302-302
Authors:
LODE HN
HANDGRETINGER R
SCHUERMAN U
SEITZ G
KLINGEBIEL T
NIETHAMMER D
BECK J
Citation: Hn. Lode et al., DETECTION OF NEUROBLASTOMA-CELLS IN CD34(-CELLS USING A COMBINATION OF TYROSINE-HYDROXYLASE NESTED RT-PCR AND ANTIGANGLIOSIDE G(D2) IMMUNOCYTOCHEMISTRY() SELECTED PERIPHERAL STEM), European journal of cancer, 33(12), 1997, pp. 2024-2030
Authors:
SEITZ G
RENNER S
RIETH A
LODE HN
NIETHAMMER D
BRUCHELT G
KOHLE H
SCHLUDE HM
STEGMANN HB
Citation: G. Seitz et al., 6-FLUORODOPAMINE DESTROYS CATECHOLAMINERGIC CELLS MORE SELECTIVELY THAN 6-HYDROXYDOPAMINE, European journal of cell biology, 72, 1997, pp. 83-83
Authors:
XIANG R
LODE HN
DOLMAN CS
DREIER T
VARKI NM
QIAN XQ
LO KM
LAN Y
SUPER M
GILLIES SD
REISFELD RA
Citation: R. Xiang et al., ELIMINATION OF ESTABLISHED MURINE COLON-CARCINOMA METASTASES BY ANTIBODY-INTERLEUKIN-2 FUSION PROTEIN THERAPY, Cancer research, 57(21), 1997, pp. 4948-4955
Authors:
LODE HN
XIANG R
DREIER T
GILLIES SD
REISFELD RA
Citation: Hn. Lode et al., NK-CELL MEDIATED ERADICATION OF NEUROBLASTOMA METASTASES TO BONE-MARROW BY TARGETED INTERLEUKIN-2 THERAPY, Blood, 90(10), 1997, pp. 1229-1229
Authors:
BRUCHELT G
KLINGEBIEL T
TREUNER J
BECK J
LODE HN
SEITZ G
NIETHAMMER D
Citation: G. Bruchelt et al., RADIOLABELED METAIODOBENZYLGUANIDINE (MIBG) IN DIAGNOSIS AND THERAPY OF NEUROBLASTOMA - RESULTS FROM BASIC RESEARCH (REVIEW), International journal of oncology, 6(3), 1995, pp. 705-712
Authors:
LODE HN
BRUCHELT G
SEITZ G
GEBHARDT S
GEKELER V
NIETHAMMER D
BECK J
Citation: Hn. Lode et al., REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION (RT-PCR) ANALYSIS OF MONOAMINE TRANSPORTERS IN NEUROBLASTOMA CELL-LINES - CORRELATIONS TO METAIODOBENZYLGUANIDINE (MIBG) UPTAKE AND TYROSINE-HYDROXYLASE GENE-EXPRESSION, European journal of cancer, 31A(4), 1995, pp. 586-590
Authors:
LODE HN
BRUCHELT G
ZINSSER D
BAADER SL
RIETH AG
SCHADE UF
NIETHAMMER D
Citation: Hn. Lode et al., ASCORBIC-ACID INDUCES LIPID-PEROXIDATION ON NEUROECTODERMAL SK-N-LO CELLS WITH HIGH ENDOGENOUS FERRITIN CONTENT AND LOADED WITH MAB FERRITIN IMMUNOCONJUGATES, Anticancer research, 14(5A), 1994, pp. 1903-1906
Authors:
BAADER SL
BRUCHELT G
CARMINE TC
LODE HN
RIETH AG
NIETHAMMER D
Citation: Sl. Baader et al., ASCORBIC-ACID-MEDIATED IRON RELEASE FROM CELLULAR FERRITIN AND ITS RELATION TO THE FORMATION OF DNA STRAND BREAKS IN NEUROBLASTOMA-CELLS, Journal of cancer research and clinical oncology, 120(7), 1994, pp. 415-421
Authors:
GEBHARDT S
KRAFT K
LODE HN
NIETHAMMER D
SCHMIDT KH
BRUCHELT G
Citation: S. Gebhardt et al., DETERMINATION OF ASCORBIC-ACID BY ISOTACHOPHORESIS WITH REGARD TO ITSPOTENTIAL IN NEUROBLASTOMA THERAPY, Journal of chromatography, 638(2), 1993, pp. 235-240